Long-term effect on blood pressure of early brief treatment by different antihypertensive agents:: A study in the Prague hypertensive rat

被引:21
作者
Heller, J [1 ]
Hellerová, S [1 ]
机构
[1] Inst Clin & Expt Med, Dept Expt Med, CZ-14000 Prague 4, Czech Republic
关键词
early brief treatment of hypertension; Prague hypertensive rat; renin-angiotensin system;
D O I
10.1159/000025898
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In the Prague hypertensive rat (PHR), a strain of genetic hypertension derived from Wistar, administration of various antihypertensive drugs (AHD) during the developmental phase of hypertension (weeks 5-9 of life) prevents the rise of blood pressure. However, only drugs blocking the renin-angiotensin system (RAS, i.e. AT1-antagonist losartan and ACE inhibitor perindopril) have a longterm effect on blood pressure leading to values of systolic blood pressure (SBP) of 174.5+/-14.5 and 169.8+/-15.3 mmHg, respectively, at week 30. At this time, control, untreated PHR have a SEP of 222.0+/-16.6 mmHg (p<0.01 far both groups); age-matched PNR (Prague normotensive rat, bred in parallel with PHR from the same parent pair) exhibit values as low as 123.3+/-11.7 mmHg (p<0.01 from all other values). When losartan was administered to another group of PHR not only at weeks 5-9 but once more at weeks of 15-19 of age, the values of their SEP at week 30 were 156.8+/-12.64 mmHg, i.e., values significantly (p<0.01) different not only from 239.7+/-17.59 mmHg (value of the untreated PHR group) but also from 174.5+/-14.5 mmHg (value of PHR to which losartan was administered only once, at weeks 5-9). Thus, twice repeated administration of losartan In young age almost normalizes blood pressure deep into adult age. Proteinuria, a common finding in adult PHR, is also significantly lower in adult age in both groups receiving at weeks 5-9 drugs blocking RAS; the values at week 30 are 4.0+/-0.26 mg/24 h/rat in the losartan and 3.87+/-0.27 in the perindopril group, in contrast to 12.8+/-1.08 (p<0.01 for both groups) in control PHR. In conclusion, early brief administration (weeks 5-9 of life) of PAS-blocking agents to PHR led to long-term antihypertensive and antiproteinuric effects. These effects were significantly intensified by a second brief administration at weeks 15-19.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 20 条
[1]   ENALAPRIL CAN PREVENT VASCULAR AMPLIFIER DEVELOPMENT IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
ADAMS, MA ;
BOBIK, A ;
KORNER, PI .
HYPERTENSION, 1990, 16 (03) :252-260
[2]   CONVERTING-ENZYME INHIBITION AND ITS WITHDRAWAL IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
CAMPBELL, DJ ;
DUNCAN, AM ;
KLADIS, A ;
HARRAP, SB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (03) :426-436
[3]  
CHRISTENSEN KL, 1989, J HYPERTENS, V80, P533
[4]   COMPARED MYOCARDIAL AND VASCULAR EFFECTS OF CAPTOPRIL AND DIHYDRALAZINE DURING HYPERTENSION DEVELOPMENT IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
FRESLON, JL ;
GIUDICELLI, JF .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 80 (03) :533-543
[5]   RENIN-ANGIOTENSIN SYSTEM IN NEONATAL RATS - INDUCTION OF A RENAL ABNORMALITY IN RESPONSE TO ACE-INHIBITION OR ANGIOTENSIN-II ANTAGONISM [J].
FRIBERG, P ;
SUNDELIN, B ;
BOHMAN, SO ;
BOBIK, A ;
NILSSON, H ;
WICKMAN, A ;
GUSTAFSSON, H ;
PETERSEN, J ;
ADAMS, MA .
KIDNEY INTERNATIONAL, 1994, 45 (02) :485-492
[6]   CAPTOPRIL AND HYPERTENSION DEVELOPMENT IN THE SHR [J].
GIUDICELLI, JF ;
FRESLON, JL ;
GLASSON, S ;
RICHER, C .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1980, 2 (06) :1083-1096
[7]  
GUMULKA W S, 1984, Acta Physiologica Polonica, V35, P41
[8]   BRIEF ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR TREATMENT IN YOUNG SPONTANEOUSLY HYPERTENSIVE RATS REDUCES BLOOD-PRESSURE LONG-TERM [J].
HARRAP, SB ;
VANDERMERWE, WM ;
GRIFFIN, SA ;
MACPHERSON, F ;
LEVER, AF .
HYPERTENSION, 1990, 16 (06) :603-614
[9]   THE PRAGUE HYPERTENSIVE RAT - A NEW MODEL OF GENETIC-HYPERTENSION [J].
HELLER, J ;
HELLEROVA, S ;
DOBESOVA, Z ;
KUNES, J ;
ZICHA, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1993, 15 (05) :807-818
[10]   Long-term inhibition of the renin-angiotensin System in genetic hypertension: Analysis of the impact on blood pressure and cardiovascular structural changes [J].
Lundie, MJ ;
Friberg, P ;
Kline, RL ;
Adams, MA .
JOURNAL OF HYPERTENSION, 1997, 15 (04) :339-348